Finecure Pharmaceuticals Ltd

- Hem Securities Ltd

Initial public offering of up to 43,40,000* equity shares of face value of Rs. 10 each (The Equity Shares), at an offer price of Rs. [*] per equity share for cash, aggregating up to Rs. [*] crores[Public Offer] comprising of a fresh issue of up to 36,40,000 equity shares aggregating Rs. [*] crores [Fresh Issue] and an offer for sale of up to 7,00,000 equity shares aggregating to Rs. [*] comprising an offer of up to 1,00,000 equity shares aggregating to Rs. [*] crores by Mr. Vikash Rajgarhia, up to 1,00,000 equity shares aggregating to Rs. [*] crores by Mr. Vivek Rajgarhia, up to 1,00,000 equity shares aggregating to Rs. [*] crores by Mr. Vishal Rajgarhia, up to 1,00,000 equity shares aggregating to Rs. [*] crores by Ms. Ushadevi Rajgarhia, up to 1,00,000 equity shares aggregating to Rs. [*] crores by Ms. Pooja Rajgarhia, up to 1,00,000 equity shares aggregating to Rs. [*] crores by Ms. Priti Rajgarhia and up to 1,00,000 equity shares aggregating to Rs. [*] crores by Ms. Archana Rajgarhia (The promoters/promoter group selling shareholders) out of which up to [*] equity shares of face value of Rs. 10 each, at an offer price of Rs. [*] per equity share for cash, aggregating up to Rs. [*] crores will be reserved for subscription by the market maker to the offer (The Market Maker Reservation Portion). The offer less market maker reservation portion i.e. Offer of [*] equity shares of face value of Rs. 10 each, at an offer price of Rs. [*] per equity share for cash, aggregating up to Rs. [*] crores is hereinafter referred to as the Net Offer. The public offer and net offer will constitute [*]% and [*]% respectively of the post- offer paid-up equity share capital of the company.The Face value of the equity shares is Rs. 10 each.

  • Issue

    • Opens OnInvalid date
    • Closes OnInvalid date
  • Money Payable On

    • Application0
    • Allotment0
  • Project Cost (Cr.)0
  • Post Issue Equity Share Capital (Cr.)0
  • Issue Price (D)0

Further Multiples of: 0

Projects

  • Promoted By
    • Listing At - NSE - SME
    • Registrar to the Issue - Link Intime India Pvt Ltd

    612-615 Anand Mangal Complex Nr Parimal Garden Ellisbridge Ahmedabad

    Gujarat- 380006

    Phone - 91-79-49030405

    Fax - 91-79-49030400

    Email - compliance@finecurepharma.com

    Website - www.finecurepharma.com

    Ready to invest with us?

    Share your Mobile Number with us and get started

    • +91|
    scrollToTop